|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: NEK6 |
Gene summary for NEK6 |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | NEK6 | Gene ID | 10783 |
| Gene name | NIMA related kinase 6 | |
| Gene Alias | SID6-1512 | |
| Cytomap | 9q33.3 | |
| Gene Type | protein-coding | GO ID | GO:0000070 | UniProtAcc | Q9HC98 |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 10783 | NEK6 | HCC2_Meng | Human | Liver | HCC | 1.02e-05 | -6.76e-02 | 0.0107 |
| 10783 | NEK6 | HCC1 | Human | Liver | HCC | 6.34e-10 | 3.48e+00 | 0.5336 |
| 10783 | NEK6 | HCC2 | Human | Liver | HCC | 1.45e-04 | 3.33e+00 | 0.5341 |
| 10783 | NEK6 | S014 | Human | Liver | HCC | 3.96e-10 | 5.06e-01 | 0.2254 |
| 10783 | NEK6 | S015 | Human | Liver | HCC | 1.67e-08 | 5.19e-01 | 0.2375 |
| 10783 | NEK6 | S016 | Human | Liver | HCC | 1.80e-14 | 5.54e-01 | 0.2243 |
| 10783 | NEK6 | S027 | Human | Liver | HCC | 2.04e-18 | 1.50e+00 | 0.2446 |
| 10783 | NEK6 | S028 | Human | Liver | HCC | 4.27e-34 | 1.66e+00 | 0.2503 |
| 10783 | NEK6 | S029 | Human | Liver | HCC | 5.59e-35 | 1.98e+00 | 0.2581 |
| 10783 | NEK6 | RNA-P17T-P17T-4 | Human | Lung | IAC | 5.82e-05 | 6.66e-01 | 0.343 |
| 10783 | NEK6 | RNA-P17T-P17T-6 | Human | Lung | IAC | 8.00e-04 | 5.36e-01 | 0.3385 |
| 10783 | NEK6 | RNA-P17T-P17T-8 | Human | Lung | IAC | 1.11e-02 | 5.16e-01 | 0.3329 |
| 10783 | NEK6 | RNA-P6T2-P6T2-3 | Human | Lung | IAC | 2.18e-02 | 1.83e-01 | -0.013 |
| 10783 | NEK6 | C04 | Human | Oral cavity | OSCC | 4.88e-12 | 5.51e-01 | 0.2633 |
| 10783 | NEK6 | C21 | Human | Oral cavity | OSCC | 1.13e-28 | 8.65e-01 | 0.2678 |
| 10783 | NEK6 | C30 | Human | Oral cavity | OSCC | 2.52e-60 | 2.38e+00 | 0.3055 |
| 10783 | NEK6 | C43 | Human | Oral cavity | OSCC | 8.65e-25 | 5.12e-01 | 0.1704 |
| 10783 | NEK6 | C51 | Human | Oral cavity | OSCC | 1.51e-15 | 6.22e-01 | 0.2674 |
| 10783 | NEK6 | C06 | Human | Oral cavity | OSCC | 1.23e-11 | 1.43e+00 | 0.2699 |
| 10783 | NEK6 | C07 | Human | Oral cavity | OSCC | 4.63e-04 | 3.99e-01 | 0.2491 |
| Page: 1 2 3 4 5 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Esophagus |  | ESCC: Esophageal squamous cell carcinoma |
| HGIN: High-grade intraepithelial neoplasias | ||
| LGIN: Low-grade intraepithelial neoplasias | ||
| Liver |  | HCC: Hepatocellular carcinoma |
| NAFLD: Non-alcoholic fatty liver disease | ||
| Lung |  | AAH: Atypical adenomatous hyperplasia |
| AIS: Adenocarcinoma in situ | ||
| IAC: Invasive lung adenocarcinoma | ||
| MIA: Minimally invasive adenocarcinoma | ||
| Oral Cavity |  | EOLP: Erosive Oral lichen planus |
| LP: leukoplakia | ||
| NEOLP: Non-erosive oral lichen planus | ||
| OSCC: Oral squamous cell carcinoma | ||
| Thyroid |  | ATC: Anaplastic thyroid cancer |
| HT: Hashimoto's thyroiditis | ||
| PTC: Papillary thyroid cancer |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD |  |
| Colorectum | SER |  |
| Colorectum | MSS |  |
| Colorectum | MSI-H |  |
| Colorectum | FAP |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| GO:014001414 | Esophagus | ESCC | mitotic nuclear division | 218/8552 | 287/18723 | 6.17e-26 | 1.78e-23 | 218 |
| GO:0022411111 | Esophagus | ESCC | cellular component disassembly | 305/8552 | 443/18723 | 1.94e-23 | 4.57e-21 | 305 |
| GO:000007011 | Esophagus | ESCC | mitotic sister chromatid segregation | 138/8552 | 168/18723 | 1.37e-22 | 2.63e-20 | 138 |
| GO:00008194 | Esophagus | ESCC | sister chromatid segregation | 157/8552 | 202/18723 | 8.41e-21 | 1.33e-18 | 157 |
| GO:003304416 | Esophagus | ESCC | regulation of chromosome organization | 145/8552 | 187/18723 | 3.80e-19 | 4.31e-17 | 145 |
| GO:000705911 | Esophagus | ESCC | chromosome segregation | 238/8552 | 346/18723 | 1.72e-18 | 1.82e-16 | 238 |
| GO:004477216 | Esophagus | ESCC | mitotic cell cycle phase transition | 281/8552 | 424/18723 | 4.63e-18 | 4.45e-16 | 281 |
| GO:190285015 | Esophagus | ESCC | microtubule cytoskeleton organization involved in mitosis | 116/8552 | 147/18723 | 1.25e-16 | 9.91e-15 | 116 |
| GO:000734615 | Esophagus | ESCC | regulation of mitotic cell cycle | 293/8552 | 457/18723 | 8.00e-16 | 5.64e-14 | 293 |
| GO:000705214 | Esophagus | ESCC | mitotic spindle organization | 97/8552 | 120/18723 | 2.17e-15 | 1.33e-13 | 97 |
| GO:000705114 | Esophagus | ESCC | spindle organization | 134/8552 | 184/18723 | 5.70e-14 | 2.87e-12 | 134 |
| GO:00482853 | Esophagus | ESCC | organelle fission | 301/8552 | 488/18723 | 4.64e-13 | 2.12e-11 | 301 |
| GO:00988133 | Esophagus | ESCC | nuclear chromosome segregation | 187/8552 | 281/18723 | 1.00e-12 | 4.36e-11 | 187 |
| GO:004312318 | Esophagus | ESCC | positive regulation of I-kappaB kinase/NF-kappaB signaling | 132/8552 | 186/18723 | 2.07e-12 | 8.58e-11 | 132 |
| GO:0043122110 | Esophagus | ESCC | regulation of I-kappaB kinase/NF-kappaB signaling | 167/8552 | 249/18723 | 6.11e-12 | 2.32e-10 | 167 |
| GO:00002802 | Esophagus | ESCC | nuclear division | 270/8552 | 439/18723 | 1.17e-11 | 4.24e-10 | 270 |
| GO:000724919 | Esophagus | ESCC | I-kappaB kinase/NF-kappaB signaling | 183/8552 | 281/18723 | 3.02e-11 | 1.01e-09 | 183 |
| GO:190198713 | Esophagus | ESCC | regulation of cell cycle phase transition | 242/8552 | 390/18723 | 3.86e-11 | 1.26e-09 | 242 |
| GO:190199013 | Esophagus | ESCC | regulation of mitotic cell cycle phase transition | 191/8552 | 299/18723 | 1.35e-10 | 3.94e-09 | 191 |
| GO:000699713 | Esophagus | ESCC | nucleus organization | 96/8552 | 133/18723 | 4.66e-10 | 1.21e-08 | 96 |
| Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| Page: 1 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| NEK6 | SNV | Missense_Mutation | c.469N>C | p.Glu157Gln | p.E157Q | Q9HC98 | protein_coding | deleterious(0.01) | probably_damaging(0.997) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
| NEK6 | SNV | Missense_Mutation | novel | c.686N>A | p.Arg229His | p.R229H | Q9HC98 | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-BH-A18L-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
| NEK6 | SNV | Missense_Mutation | c.808N>G | p.Leu270Val | p.L270V | Q9HC98 | protein_coding | tolerated(0.11) | possibly_damaging(0.664) | TCGA-D8-A27G-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
| NEK6 | insertion | Frame_Shift_Ins | novel | c.607_608insCTGATGCCCGTTGGAAC | p.Met203ThrfsTer24 | p.M203Tfs*24 | Q9HC98 | protein_coding | TCGA-A8-A08H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
| NEK6 | SNV | Missense_Mutation | rs879292381 | c.577N>A | p.Ala193Thr | p.A193T | Q9HC98 | protein_coding | deleterious(0) | probably_damaging(0.989) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
| NEK6 | SNV | Missense_Mutation | c.341N>T | p.Glu114Val | p.E114V | Q9HC98 | protein_coding | deleterious(0.01) | possibly_damaging(0.886) | TCGA-C5-A1MI-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | PD | |
| NEK6 | SNV | Missense_Mutation | rs750746819 | c.217N>T | p.Arg73Cys | p.R73C | Q9HC98 | protein_coding | tolerated_low_confidence(0.11) | benign(0.006) | TCGA-MA-AA3W-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
| NEK6 | SNV | Missense_Mutation | c.959N>C | p.Ile320Thr | p.I320T | Q9HC98 | protein_coding | deleterious(0) | probably_damaging(0.972) | TCGA-AA-3811-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD | |
| NEK6 | SNV | Missense_Mutation | c.661N>C | p.Lys221Gln | p.K221Q | Q9HC98 | protein_coding | deleterious(0.03) | probably_damaging(0.999) | TCGA-AA-3966-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
| NEK6 | SNV | Missense_Mutation | rs183673274 | c.230N>T | p.Ala77Val | p.A77V | Q9HC98 | protein_coding | tolerated(0.1) | benign(0.051) | TCGA-AD-A5EJ-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
| Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| 10783 | NEK6 | DRUGGABLE GENOME, KINASE, ENZYME, SERINE THREONINE KINASE | inhibitor | 249565885 |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |